ArticleHepatology (Baltimore, Md.)2004

The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?

Michael TraunerPubMed ↗Publisher ↗

No numbers read from the abstract.